BiologicalActivity
DualinhibitorofAblandSrckinases(IC50=1.2nMforSrcinanenzymaticassay).Displaysantiproliferativeactivityagainstchronicmyelogenousleukemia(CML)cellsanddecreasesthemotilityandinvasionofbreastcancercelllines.Alsoexhibitspotentantiproliferativeactivityinanchorage-independent,Src-transformedratfibroblasts(IC50=100nM).DisplaysselectivityforSrcovernon-Srcfamilykinasessuchasgrowthfactorreceptortyrosinekinases.
LicensingInformation
SoldforresearchpurposesunderagreementfromPfizerInc.
CompoundLibraries
BosutinibisalsoofferedaspartoftheTocriscreenPlus,TocriscreenKinaseInhibitorToolboxIIandTocriscreenLibraryofFDA-ApprovedCompounds.FindoutmoreaboutcompoundlibrariesavailablefromTocris.
TechnicalData
M.Wt | 530.45 |
Formula | C26H29Cl2N5O3 |
Storage | Storeat+4°C |
Purity | ≥99% |
CASNumber | 380843-75-4 |
PubChemID | 5328940 |
InChIKey | UBPYILGKFZZVDX-UHFFFAOYSA-N |
Smiles | ClC1=CC(Cl)=C(OC)C=C1NC3=C(C#N)C=NC2=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23 |
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
SolubilityData
Solvent | MaxConc.mg/mL | MaxConc.mM | |
---|---|---|---|
Solubility | |||
DMSO | 53.05 | 100 | |
ethanol | 13.26 | 25 |
PreparingStockSolutions
Thefollowingdataisbasedontheproductmolecularweight530.45.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.
Concentration/SolventVolume/Mass | 1mg | 5mg | 10mg |
---|---|---|---|
1mM | 1.89mL | 9.43mL | 18.85mL |
5mM | 0.38mL | 1.89mL | 3.77mL |
10mM | 0.19mL | 0.94mL | 1.89mL |
50mM | 0.04mL | 0.19mL | 0.38mL |